Poland – Research laboratory services – Usługa sekwencjonowania NGS (ang. Next Generation Sequencing)
Opportunity Score
Confidence: 60%
Complexity: medium
15 days
Deadline
services
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
The tender is for Next Generation Sequencing (NGS) services for bacterial DNA and RNA samples, including library preparation, sequencing (short-read and long-read), bioinformatics analysis, and reporting. The contract is for 12 months, with sample batches of 1-200. The buyer is the National Institute of Medicines (Narodowy Instytut Leków) in Warsaw, Poland. The procedure is open, with no lot division allowed. The estimated value is not disclosed. Key eligibility requirements include experience, technical capability, and quality certifications. Award is based on price (60%) and technical quality (40%). Submission is electronic via the buyer's platform by 30 June 2026.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Single contract: no partial bids, no variant bids, no option right
- Services must be performed in accordance with the detailed description in SWZ Attachment 1
- DNA input: total ≥500ng (1.5µg for Nanopore), concentration >5ng/µl (70ng/µl for Nanopore), purity A260/A280 ≥1.8
Buyer
Name
Narodowy Instytut Leków
Location
Warszawa, POL
Website
Identifier
NIP 5213212384
Lots (1)
Single lot covering all NGS sequencing services as described. No partial bids allowed.
Procurement Details
Publication
26 May 2026
Deadline
30 Jun 2026, 08:00
Procedure
open
Contract
services
Duration
12 MONTH
Language
POL
Publication #
361272-2026
Classification
Performance: Poland
Documents (2)
Opportunity Score
Confidence: 60%
Complexity: medium
15 days
Deadline
services
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation